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With  the  ever-increasing  clinical  application  of  cell-based  therapies,  it is considered  critical  to  develop
systems  that  facilitate  the  storage  and  distribution  of cell  therapy  products  (CTPs)  between  sites of  man-
ufacture  and  the clinic.  For  such systems  to be  realized,  it is  essential  that  downstream  bioprocessing
strategies  be  established  that  are  scalable,  reproducible  and  do not  inﬂuence  the  viability  or  function  of
the living  biologic.  To this  end,  we examined  alginate-encapsulation  as  a method  to  heighten  the  preser-
vation  of  human  adipose-derived  stem  cells  (hASCs)  during  hypothermic  storage,  and  establish  a  scalable
process  for  high-volume  production.  A drop-wise  method  for  scalable  alginate  bead  generation,  using
calcium  as  the  cross-linker,  was  modiﬁed  to  enable  the  yield  of up to 3500  gelled  beads  per minute.
The  effect  of  alginate  concentration  on  the  viscosity  of non-gelled  sodium  alginate  and  the  mechanical
properties  and  internal  structure  of  calcium-crosslinked  alginate  in  response  to  different  alginate  and
calcium concentrations  were  investigated.  Mechanical  strength  was  chieﬂy  dependent  on  alginate  con-
centration  and  1.2%  alginate  cross-linked  with  100  mM  calcium  chloride  could  withstand  stress  in the
order  of  35  kPa.  Upon  selection  of  appropriate  parameters,  we demonstrated  the suitability  of  using  this
method  for  immobilizing  human  stem  cells.  Encapsulated  hASCs  demonstrated  no loss  in cell  viability,
and  had  a uniform  distribution  after  high-volume  production.  Following  storage,  released  cells  were  able
to attach  and  recover  a normal  morphology  upon  return  to  culture  conditions.  Thus  we present  a  scalable
method  for  stem  cell  encapsulation  and  storage  for  application  within  the  cell  therapy  supply  chain.
© 2016  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license. Introduction
Advances in cell-based therapeutics have been considerable in
ecent times, with increasing numbers of clinical trials registered
or the treatment of a vast array of disorders ranging from car-
iovascular disease to cancer [1–3]. Many of these trials are in
hase III of development and, accompanying this, is the Food andPlease cite this article in press as: S. Swioklo, et al., Proce
encapsulated stem cells for storage and distribution throughou
http://dx.doi.org/10.1016/j.procbio.2016.06.005
rug Administration (FDA)- or European Medicines Agency (EMA)-
pproval of a number of cell therapy products (CTPs) as previously
iscussed [4].
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One of the major hurdles faced for the clinical delivery of CTPs
to the patient is in their upstream and downstream bioprocessing.
In order to satisfy the number of cells required for cell based-
therapies, typically being up to 1–2 × 106 cells/kg for mesenchymal
stem cell (MSC)-based therapies [5], much effort has been spent in
optimizing the expansion and reproducibility of cells for patient
delivery [6]. Whilst it is fundamental to have in place rigorous plat-
forms for upstream production of cell therapy products, it is also of
utmost importance to develop scalable downstream bioprocessing
strategies in order to meet clinical demand. Additionally, the ﬁnal
cell therapy product must be in a form that can be easily packaged,
stored and distributed throughout the cell therapy supply chain.
Alginate, a natural polysaccharide derived from seaweed, has
been used extensively as a hydrogel scaffold for cell delivery
[7–9] due to its ease of gelation/de-gelation, biocompatibility,ss parameters for the high-scale production of alginate-
t the cell therapy supply chain, Process Biochem (2016),
mass transfer properties, and its shielding effect facilitating the
immunoisolation of encapsulated cells. As well as its use in scalable
manufacturing for cell therapy applications [10], alginate has been
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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emonstrated to be a useful matrix for the handling and storage of
ells at hypothermic temperatures, whilst preserving cell viability
nd function [4,10–13].
The hypothermic storage of cells involves their maintenance, in
 suspended state, at temperatures between 0 ◦C and 32 ◦C. Cells
re then re-activated upon return to normothermic temperatures
14]. Due to the biological and technical issues associated with
ryopreservation [15,16], the risk of thawing and wastage dur-
ng transport, as well as the cost of infrastructure and equipment
ecessary for the storage and distribution of cryopreserved cells
17], there is much interest in the use of hypothermic preservation
ithin the cell therapy supply chain [18,19]. The restricted, inﬂex-
ble shelf lives associated with hypothermically stored CTPs can,
owever, still result in a high wastage of materials [20]. Therefore,
ethods that are able to improve the hypothermic preservation of
ell viability and function, such as alginate-encapsulation, have a
onsiderable potential.
In order to fulﬁll this potential, it is important to establish a
ownstream process for cell encapsulation that is scalable, repro-
ucible and cost-effective. It is also imperative that the process
oes not affect cell viability and/or function. The gelation of alginate
s most commonly performed through crosslinking polymers with
ivalent cations, such as calcium. This simple method of gelation
llows the formation of alginate hydrogels of different shapes and
imensions, but most frequently alginate beads are produced. The
ethod for bead generation can be performed by either external
r internal gelation. The former involves the diffusion of an exoge-
ous source of cations for alginate crosslinking, whereas internal
elation requires an insoluble source of crosslinking ions within
he alginate. For bead generation, the latter of these is carried out
hrough the suspension of alginate solution in oil phase followed
y the release of crosslinking ions, most typically by lowering pH
hrough the addition of organic acids [21–23]. However, internal
elation is also associated with (1) typically long gelling times in
he range of several hours [24] and (2) the necessity to lower the pH
alue, which may  inﬂuence the viability of immobilized cells [22].
he advantages of externally gelled hydrogels are; (1) short gelling
imes (in the range of seconds to minutes), and (2) no potential
ontamination of stem cells by oil and the associated difﬁculties
n separating the gelled beads from the oil phase are eliminated.
herefore, external gelation using an alginate-calcium two  phase
queous system has important advantages for stem cell encapsu-
ation, speciﬁcally for large-scale applications.
Human adipose-derived stem cells (hASCs), a source of MSCs
rom subcutaneous fat, have a considerable clinical interest with
ver 130 clinical trials being registered for their use between
ebruary 2007 and April 2015 (as listed on clinicaltrials.gov). Using
hese cells, we explored a modiﬁed drop-wise bead generation as a
ethod for scalable hASC encapsulation. We  assessed the mechan-
cal properties of non-gelled sodium alginate solubilized in PBS and
ubsequently gelled calcium-crosslinked alginate. We  then exam-
ned the mechanical strength of calcium alginate beads in response
o different alginate and calcium concentrations. Following the
election of appropriate process parameters, we demonstrated that
ncapsulating hASCs in alginate using this method did not impact
ell viability, and facilitated an even distribution of live and dead
ells throughout alginate beads. Finally, we examined hASC mor-
hology and capacity to attach (to tissue culture plastic) following
eturn to normal cell culture conditions after periods of cell storage,
emonstrating that this is a suitable method to maintain the cyto-
rotective properties of alginate whilst exploiting a highly scalable
ownstream platform.Please cite this article in press as: S. Swioklo, et al., Proce
encapsulated stem cells for storage and distribution throughou
http://dx.doi.org/10.1016/j.procbio.2016.06.005 PRESS
istry xxx (2016) xxx–xxx
2. Materials and methods
2.1. Rheological assessment of sodium alginate viscosity
The ﬂow curves of 0.6–2.4% (w/v) sodium alginate (Aldrich
brand #W201502, Sigma Aldrich, UK) in PBS (Oxoid brand, Fisher
Scientiﬁc, UK) was  measured using a Bohlin rheometer with 4 cm
cone-and-plate geometry (Malvern instrument, UK).
2.2. Preparation of alginate beads
The gelation of alginate beads was performed in a bafﬂed
jacketed stirred vessel of 75 mm diameter ﬁtted with a 42 mm
Rushton turbine impeller. A volume of 250 mL,  100 mM CaCl2 was
charged into the vessel kept at 20 ◦C and stirred at 130 rpm to
uniformly suspend gelling alginate beads. A custom-made extru-
sion head composed of 9 needles (internal diameter 0.6 mm)  was
placed 10–15 mm above the calcium solution. Alginate solution
was extruded at a ﬂow rate of 22 mL/min using a peristaltic pump
and the formed beads were subsequently stirred and allowed to
gel for 10 min. The images of gelled beads were recorded in-situ
using a stereo-microscope ﬁtted with a video camera and bead size
distribution and mean diameter were measured by image analysis.
2.3. Measurement of mechanical properties of gelled beads
The mechanical properties of beads manufactured with differ-
ent concentrations of alginate and calcium chloride (CaCl2) were
measured using a Static Materials Testing Machine (Zwick/Roell,
2030). Gelled beads (∼2.8 mm diameter) were compressed by a
stainless steel probe connected to a force transducer and a com-
puter allowing precise control of the probe position and speed of
compression. During the test the compressive force and the dis-
placement were continuously recorded. The zero displacement was
deﬁned when the probe touched the surface of the beads (zero
force). Deformation was  deﬁned as the displacement divided by
the bead’s diameter. The stress was deﬁned as the force divided by
the area of the initial cross section of the bead. For every experi-
mental condition, 10 beads were measured and the average values
of displacement and force were calculated.
2.4. Structural characterization of gelled alginate beads by ESEM
The internal structure of gelled beads was  examined by an
Environmental Scanning Electron Microscope (ESEM, Philips XL30).
Gelled beads withdrawn from the calcium bath were washed three
times in double distilled water followed by washing for 15 min
in each of the following ethanol solutions: 50% (v/v), 70% (v/v),
90% (v/v) and 100%. Then, the beads were dehydrated using crit-
ical point drying, fractured to expose an internal structure, placed
on aluminum stubs, and coated with gold before examination using
ESEM.
2.5. hASC culture
hASCs obtained from the subcutaneous fat of three healthy
donors (Invitrogen, UK), were used for experiments. Cells were
isolated from both male and female subjects (aged 45–63 years)
and purity was  determined by the manufacturer as cells being
≥95% positive for CD29, CD44, CD73, CD90, CD105, and CD166 and
≤2% positive for CD14, CD31 and CD45 surface antigen expres-
sion. Following recovery from cryostorage, cells were seeded atss parameters for the high-scale production of alginate-
t the cell therapy supply chain, Process Biochem (2016),
800 cells/cm2 and maintained in reduced-serum (RS) growth media
[MesenPROTM RS medium containing 2 mM  GlutaMAXTM and 1%
(v/v) antibiotic-antimycotic (all from Life Technologies, UK)] in a
humidiﬁed incubator at 37 ◦C and 5% CO2 with medium changes
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Big. 1. Rheology of sodium alginate solutions. (A) ﬂow curves at different alginate c
s  a function of alginate concentration.
very 3–4 days until approximately 80% conﬂuence was reached.
ells were harvested using TrypLETM Express enzyme (Life Tech-
ologies, UK).
.6. Encapsulation of hASCs
A sample of harvested cells was incubated with 0.2% Trypan Blue
Invitrogen, UK) for 3 min  before counting viable (unstained) and
ead (stained) cells using a Neubauer haemocytometer. A 30 mL
uspension of 1 × 106 viable cells/mL in growth media was  then
ixed with 30 mL  2.4% (w/v) sodium alginate in PBS. Alginate beads
ontaining cells were then extruded as per materials and methods
ection 2.2. Following gelation, beads were washed brieﬂy in PBS
efore storing approximately 5 mL  of gelled beads in tightly sealed
5 mL  centrifuge tubes containing 10 mL  growth medium to occupy
he full volume of the tube.
.7. Determination of percentage cell viability
Cells were assessed for percentage cell viability before, imme-
iately after, and 24 h after encapsulation. For the assessment of
ncapsulated samples, cells were ﬁrst released by dissolving cal-
ium alginate using 100 mM trisodium citrate (Sigma, UK) for 5 min
t room temperature. Trisodium citrate was diluted using PBS
efore separating cells by centrifugation. Released cells were resus-
ended in growth medium and incubated with 0.2% Trypan Blue
Invitrogen, UK) for 3 min  before counting viable (unstained) and
ead (stained) cells using a Neubauer haemocytometer. Percentage
iability was calculated as the number of viable cells divided by the
otal number of cells, multiplied by 100.
.8. Determination of live cell distribution throughout alginate
eads
48 h after cell encapsulation, phase-contrast images were cap-
ured using an Axiovert 200 M inverted microscope (Zeiss, UK).
ive and dead cell distribution was assessed following incuba-
ion with 1 M Calcein-AM (eBioscience, UK) and 2 M ethidium
omodimer-1 (Sigma Aldrich, UK) for 30 min  at 37 ◦C before assess-
ng cell distribution using an A1R confocal microscope (Nikon,Please cite this article in press as: S. Swioklo, et al., Proce
encapsulated stem cells for storage and distribution throughou
http://dx.doi.org/10.1016/j.procbio.2016.06.005
K). Further examination of cell distribution was  achieved follow-
ng incubation with 0.2 M CellTag 700 and capturing images of
eads using an Odyssey CLx Infrared imager (both from LI-COR
iosciences, UK).trations: () 0.6% (w/v), (©) 1.2% (w/v), () 1.8% (w/v), () 2.4% (w/v); (B) viscosity
2.9. Assessment of cell attachment following storage in alginate
beads
Cells were assessed for their ability to attach to tissue cul-
ture plastic under normal cell culture conditions both 1 day and
7 days after encapsulation (and release) and compared to non-
encapsulated cells treated in the same manner. For the longer
storage time, cells were stored at 15 ◦C in a cooled incubator with
atmospheric O2 and CO2 in tightly sealed 15 mL centrifuge tubes
containing growth medium to occupy the full volume of the tube
(as per materials and methods Section 2.6). Non-encapsulated cells
were simply suspended in the same volume of growth medium
and stored in tightly sealed tubes. Following release from stor-
age, calcium alginate beads were dissolved and cells separated as
per materials and methods Section 2.7. Cells were then dissoci-
ated using TrypLE Express Enzyme (Invitrogen, UK) for 5 min  at
room temperature. This was  necessary due to aggregation of control
(non-encapsulated) samples during the storage period. Following
dissociation, an equal volume of growth medium to TrypLE Express
was added before cells were counted and plated at 5000 cells/cm2
in 24-well plates containing growth medium. After 24 h at 37 ◦C, 5%
CO2 in a humidiﬁed incubator, images were captured of attached
cells.
2.10. Statistical analysis
Statistical analysis for percentage viability measurements was
carried out using GraphPad Prism (v6.00). Data are expressed as
means of values from three separate donors ± standard deviation
(SD). Statistical comparisons were made using one-way repeated
measures Analysis of Variance (ANOVA) with Bonferroni post hoc
tests.
3. Results and discussion
3.1. Characterization of sodium alginate solutions in PBS
Prior to bead generation, the ﬂow curves of alginate solutions in
PBS were measured over the range of alginate concentrations. Up
to alginate concentrations of 2.4% (w/v), solutions were practically
Newtonian (Fig. 1A) with viscosity increasing exponentially with
alginate concentrations (Fig. 1B). Based on the calculated intrin-
sic viscosity using the data in Fig. 1, the molecular weight of thess parameters for the high-scale production of alginate-
t the cell therapy supply chain, Process Biochem (2016),
alginate was estimated as 83 kDa ± 5.45 kDa [25–27]. The critical
concentration, where the gel encompasses the whole volume of
the solution, was estimated as 0.37% (w/v) [28]. In the experiments
discussed here the alginate concentration was  in the range from
ARTICLE ING ModelPRBI-10709; No. of Pages 8
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Cig. 2. Schematic of experimental rig used for alginate bead generation. 1- jacketed
tirred vessel, 2- home made extrusion head, 3-stirrer, 4- Rushton turbine, 5- strobe
ight, 6- microscope combined with video camera, 7- image acquisition system.
.6 to 2.4 g/ml, which is well above the critical concentration i.e.
he minimum concentration for gelation.
.2. Drop-wise method for bead generation
Of the methods established for the generation of alginate beads,
he drop-wise method is the most established and technically
east challenging. In order to increase the production rate of algi-
ate beads, the standard extrusion method was modiﬁed using
 custom-made extrusion head with multiple needles. This was
esigned in such a way to prevent coalescence of alginate on
he surface of the head whilst being easily cleaned and sterilized
see Fig. 2). Through using this approach, it was possible to yield
n increased production rate of calcium alginate beads, approxi-
ately 3500 beads/min of 2.8 ± 0.15 mm diameter and very narrow
ize distribution. Thus, this method represented a highly scalable
pproach for the production of large numbers of alginate beads
or cell immobilization. Prior to cell encapsulation, the effect of
lginate and calcium concentrations on mechanical and structural
roperties of beads generated by this method was investigated.
.3. Mechanical properties of calcium alginate beads
The mechanical properties of the gelled beads are summarized
n Figs. 3 and 4. Fig. 3A shows the stress as a function of deforma-Please cite this article in press as: S. Swioklo, et al., Proce
encapsulated stem cells for storage and distribution throughou
http://dx.doi.org/10.1016/j.procbio.2016.06.005
ion and it is clear that at around 60% deformation, gelled beads
racture (point A in Fig. 3A). Fig. 3B shows typical results of the
ress-release experiments with the characteristic hysteresis loop
here at zero stress, beads are signiﬁcantly deformed. This clearly
ig. 3. Mechanical properties of calcium alginate beads. (A) stress as a function of deforma
aCl2. PRESS
istry xxx (2016) xxx–xxx
indicates that gelled alginate beads are elasto-plastic. This was also
conﬁrmed by press-hold tests where, at constant deformation, the
compressive force gradually decreases with the relaxation time.
Elasto-plastic behavior might be explained by the high porosity
of gelled beads and it is consistent with the high permeability of
alginate gels [29,30] and ESEM measurements discussed below.
High porosity allows the inﬂow of oxygen and nutrients to and
the outﬂow of therapeutic factors, metabolites and waste products
from gelled beads conﬁrming the suitability of alginate beads for
preservation/encapsulation of stem cells.
The mechanical strength of the beads increased with alginate
concentrations (Fig. 4A). This could be explained by the fact that
as the alginate concentrations increased, the gel network became
denser and stronger, leading to the increase in overall mechani-
cal strength. However, calcium concentrations seem to have little
effect on the gel structure and mechanical strength as shown in
Fig. 4B. This is also consistent with the results of ESEM measure-
ment discussed below.
3.4. Morphology of gelled alginate beads
The effect of alginate concentrations on the morphology of
gelled beads is shown in Fig. 5. As the alginate concentration was
increased the pores inside beads became smaller. This is consistent
with the author’s previous results [13] and also with the mechanical
strength measurements discussed above showing that the strength
of beads increased with the alginate concentrations. Fig. 5 also
shows that the pore size is practically independent of calcium con-
centrations range from 0.07 to 0.15 M.  This is also consistent with
the mechanical measurement where the strength of beads is prac-
tically independent of the calcium concentrations.
It is worth noting that at high calcium concentrations, specif-
ically at 0.15 M,  calcium crystals were observed inside pores
implying calcium salt precipitation during drying.
3.5. Selection of process conditions for stem cell encapsulation
For cell encapsulation, 1.2% (w/v) alginate and 0.1 M calcium
chloride concentrations were selected. These concentrations had
been previously demonstrated to be suitable in alginate-based
systems that convey cytoprotection during hypothermic storage
[4,11,13] and were deemed appropriate following mechanical and
structural characterization. Whilst we  demonstrated that increas-
ing the concentration of sodium alginate did result in an increased
mechanical strength, which may  be favorable for durability of thess parameters for the high-scale production of alginate-
t the cell therapy supply chain, Process Biochem (2016),
ﬁnal product, the decreased pore size at higher concentrations
may  effect the mass transfer properties of the gel which could be
critical for cell survival. Additionally, the higher viscosity of more
concentrated alginate solutions may  have compromised the even
tion, (B) example of press-release curve in 1.2% (w/v) alginate gelled in and 100 mM
ARTICLE IN PRESSG ModelPRBI-10709; No. of Pages 8
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Fig. 4. Mechanical strength of alginate beads. (A) effect of alginate concentration at constant calcium concentration of 0.1 M CaCl2: (©) 1.2% (w/v) alginate, () 1.8% (w/v)
alginate, () 2.4% (w/v); (B) effect of calcium concentration at constant alginate concentration 1.2% (w/v) alginate: (©) 0.07 M CaCl2, () 0.1 M CaCl2, () 0.15 M CaCl2.
F s. (A) 1.2% (w/v) alginate, 0.1 M CaCl2; (B) 2.4% (w/v) alginate, 0.1 M CaCl2; (C) 1.2% (w/v)
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Fig. 6. The effect of processing on cell viability. Images of cells encapsulated in
alginate were monitored during gelation (A) and the percentage viability of cellsig. 5. Effect of alginate and calcium concentrations on the structure of gelled bead
lginate 0.07 M CaCl2; (D) 1.2% (w/v) alginate, 0.15 M CaCl2.
istribution of cells throughout the hydrogel, and increased the
hear stress inﬂicted on cells during distribution and extrusion,
s well as increasing the possibility of blockages forming in the
xtrusion system (the latter point was indeed observed on several
ccasions with 1.8%–2.4% (w/v) alginate concentrations). The effect
f calcium chloride concentration on the mechanical properties of
elled alginate was negligible in the range tested, whilst higher con-
entrations resulted in salt formation. We  therefore selected 0.1 M
alcium chloride as a gelling solution that allowed reproducible
ead formation and no evidence of calcium salts within the matrix.
sing these conditions, the modiﬁed drop-wise method for bead
eneration was employed to encapsulate hASCs.
.6. The effect of processing on cell viability
Due to the possible exposure of cells to shear stress during
xtrusion and gelation, it was important to determine whether thePlease cite this article in press as: S. Swioklo, et al., Proce
encapsulated stem cells for storage and distribution throughou
http://dx.doi.org/10.1016/j.procbio.2016.06.005
rocess had a negative impact on cell viability. This was performed
oth directly after processing, and 24 h after processing in order
o take into account any delayed activation of cellular stress path-
ays. An even distribution of hASCs throughout gelling alginatewas measured before, immediately after, and 24 h after encapsulation (B). Values
are expressed as means ± SD from 3 separate donors.
beads was observed during encapsulation (Fig. 6A) and encapsu-ss parameters for the high-scale production of alginate-
t the cell therapy supply chain, Process Biochem (2016),
lated cells exhibited no signiﬁcant decrease in percentage viability
(Fig. 6B) with levels of 90 ± 5%, 86 ± 3% and 88 ± 7% before, after
and 24 h after processing respectively.
Please cite this article in press as: S. Swioklo, et al., Process parameters for the high-scale production of alginate-
encapsulated stem cells for storage and distribution throughout the cell therapy supply chain, Process Biochem (2016),
http://dx.doi.org/10.1016/j.procbio.2016.06.005
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Fig. 7. The spatial distribution of cells through alginate beads. 48 h after encapsulation, hASCs in beads were examined by phase microscopy (A), infrared imaging (B) and
confocal microscopy (C–E). (C–E) hASCs were stained with calcein-AM (live indicator; green) and ethidium homodimer-1 (dead indicator: red) and maximal projection (C),
orthogonal projection (D) and 3D projection (E) images were captured. Arrowheads indicate the position of dead cells. (For interpretation of the references to colour in this
ﬁgure  legend, the reader is referred to the web  version of this article.)
Fig. 8. Morphology and attachment of encapsulated ASCs following storage. hASCs were stored for either 1 day or 7 days before plating at 5000 cells/cm2 and returning to
normal tissue culture conditions. Scale bars = 200 m.
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With the method and parameters selected for cell encapsula-
ion, it was fundamental that we determined that there was no
dverse effect on cell viability owing to shear stress as has been
eported in different alginate systems [31]. Using 1.2% (w/v) algi-
ate, cells could be dispersed easily and quickly within the matrix
efore extrusion through multiple needles and gelation by ionic
rosslinking. Using this simple drop-wise method, we  were able
o rapidly generate large numbers of beads without affecting the
ealth of cell populations.
.7. Viable and dead cell distribution throughout alginate beads
In order to further explore the spatial distribution of cells fol-
owing encapsulation, as well as their viability, we  employed a
umber of imaging techniques 48 h after bead generation. It is of
reat importance to maintain consistency in terms of cell num-
er and uniformity during production, and this must be sustained
hroughout the whole production process.
Beads exhibited a spherical appearance with a slight tail
Fig. 7A), an appearance maintained following the production of a
arge number of beads (Fig. 7B). Importantly, cell distribution was
niform as demonstrated by infrared imaging of encapsulated cells,
learly depicting the shape of the beads with greater intensity at
oints of overlap (Fig. 7B). Confocal imaging of live/dead-stained
ncapsulated cells supported the high viability demonstrated at
arlier time points, with cells exhibiting a good distribution from
rojected Z-stacks (Fig. 7C) and few dead cells (indicated by arrow-
eads). This was also apparent in orthogonal views of YZ and XZ
lanes (Fig. 7D) where both live and dead cells were distributed
hroughout the depth of the bead (dead cells indicated with arrow-
eads). The same cellular dispersal was represented by volume
rojection (Fig. 7E). The even distribution of dead cells, accompa-
ied by the absent loss of viability described earlier, conﬁrms that
ell death is not being induced by the potential external stresses
hat cells are exposed to during processing.
.8. Attachment and morphology of hASCs following release from
torage
In addition to the effect of processing on cell viability, it was  also
ssential to examine cellular function after a period of rewarming.
he deterioration of cell viability and function within 24 h of return
o normothermic conditions has been well described following cry-
preservation [32] and hypothermic storage [33,34], associated
ith the delayed activation of apoptotic and necrotic pathways.
t was also pertinent because bone marrow-derived MSCs have
een reported to have attenuated attachment following hypother-
ic  storage [35]. We therefore examined the attachment of hASCs
pon return to normal tissue culture conditions for 24 h follow-
ng hypothermic storage for 1 or 7 days. hASCs seeded 1 day after
ncapsulation exhibited a normal spindle shaped ﬁbroblast-like
orphology after 24 h in culture, demonstrating a good capac-
ty for attachment (Fig. 8). No obvious differences were observed
etween encapsulated hASCs and non-encapsulated (control) sam-
les stored in the same manner. After 7 days in storage however,
lginate-encapsulation was demonstrated to preserve attachment
Fig. 8). Whilst encapsulated cells exhibited a reasonable level of
ttachment, albeit at a slightly lower level compared to 1 day, con-
rol samples demonstrated a considerable decrease in the number
f attached cells, with a greater evidence of rounded, dead cells.
he capacity for alginate-encapsulation to preserve the capacity
or cells to attach following rewarming supports previous workPlease cite this article in press as: S. Swioklo, et al., Proce
encapsulated stem cells for storage and distribution throughou
http://dx.doi.org/10.1016/j.procbio.2016.06.005
onducted in our lab [4]. In this previous study, the hypothermic
torage of non-encapsulated hASCs at 15 ◦C resulted in a signiﬁcant
ecrease in the number of cells attaching to tissue culture plastic
fter return to normal tissue culture conditions. The encapsulation
[
[ PRESS
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of cells in 1.2% calcium alginate discs prevented this decrease in
attachment.
These results further support the suitability of this pro-
cessing approach in maintaining the cytoprotective effects of
alginate-encapsulation for hypothermic storage described previ-
ously [4,10–13].
4. Conclusions
Determining a scalable downstream processing platform that
has no effect on cell viability is paramount to a successful cell-
storage system. In this study, we  have built on previous work
demonstrating the cytoprotective effects of alginate encapsulation
[4,11–13], and explored a suitable scalable method for the produc-
tion of alginate-encapsulated stem cells for storage and distribution
throughout the cell therapy supply chain. Alginate represents a ver-
satile material with demonstrable cytoprotective effects and simple
scalability in production, thus exhibiting considerable potential in
the cell therapy industry.
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